Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Ondine Biomedical Inc - Vancouver, Canada-based life sciences company focused on photodisinfection-based therapies - Appoints medical device distributor, Distrauma Medical SL, to distribute its Steriwave nasal photodisinfection in Spain. Distrauma, a national medical device supplier focusing on surgical equipment for hospitals, is headquartered in Barcelona, Spain. ‘The primary application for Steriwave nasal photodisinfection is nasal decolonization for the prevention of healthcare-associated infections, including surgical site infections,’ Ondine says.
Current stock price: 24.75 pence
12-month change: down 57%
Copyright 2022 Alliance News Limited. All Rights Reserved.